| Sources | Names Used |
|---|---|
| GDSC1000, FIMM | Cytarabine |
| CTRPv2 | cytarabine hydrochloride |
| PharmacoGx | Cytarabine |
| Database | Identifier |
|---|---|
| Smiles: | C1=CN(C(=O)N=C1N)C2C(C(C(O2)CO)O)O.Cl |
| Inchikey: | KCURWTAZOZXKSJ-UHFFFAOYSA-N |
| Pubchem: | 5351180 |
| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TADA1 | CTRPv2 | pan-cancer | AAC | 0.25 | 4e-15 |
| mRNA | TIA1 | CTRPv2 | pan-cancer | AAC | 0.23 | 5e-15 |
| mRNA | MBTD1 | CTRPv2 | pan-cancer | AAC | 0.26 | 5e-15 |
| mRNA | FUBP1 | CTRPv2 | pan-cancer | AAC | 0.22 | 6e-15 |
| mRNA | RAG2 | GDSC1000 | pan-cancer | AAC | 0.28 | 6e-15 |
| mRNA | MND1 | CTRPv2 | pan-cancer | AAC | 0.25 | 9e-15 |
| mRNA | HNRNPA0 | CTRPv2 | pan-cancer | AAC | 0.23 | 9e-15 |
| mRNA | MED28 | CTRPv2 | pan-cancer | AAC | 0.26 | 1e-14 |
| mRNA | FBXO5 | CTRPv2 | pan-cancer | AAC | 0.23 | 1e-14 |
| mRNA | ILF3 | CTRPv2 | pan-cancer | AAC | 0.24 | 1e-14 |
